Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Lipid Mediators and Itch.

Andoh T, Kuraishi Y.

In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment. Boca Raton (FL): CRC Press/Taylor & Francis; 2014. Chapter 15.

2.

Methods for preclinical assessment of antipruritic agents and itch mechanisms independent of mast-cell histamine.

Kuraishi Y.

Biol Pharm Bull. 2015;38(5):635-44. doi: 10.1248/bpb.b15-00090. Review.

3.

Role of PAR-2 in Neuroimmune Communication and Itch.

Kempkes C, Buddenkotte J, Cevikbas F, Buhl T, Steinhoff M.

In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment. Boca Raton (FL): CRC Press/Taylor & Francis; 2014. Chapter 11.

4.

Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.

Woodward DF, Nieves AL, Spada CS, Williams LS, Tuckett RP.

J Pharmacol Exp Ther. 1995 Feb;272(2):758-65.

PMID:
7853191
5.
7.

Enhanced scratching evoked by PAR-2 agonist and 5-HT but not histamine in a mouse model of chronic dry skin itch.

Akiyama T, Carstens MI, Carstens E.

Pain. 2010 Nov;151(2):378-83. doi: 10.1016/j.pain.2010.07.024.

8.

Pruriceptors.

Ringkamp M, Meyer R.

In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment. Boca Raton (FL): CRC Press/Taylor & Francis; 2014. Chapter 9.

9.

Scratching behavior and Fos expression in superficial dorsal horn elicited by protease-activated receptor agonists and other itch mediators in mice.

Akiyama T, Merrill AW, Zanotto K, Carstens MI, Carstens E.

J Pharmacol Exp Ther. 2009 Jun;329(3):945-51. doi: 10.1124/jpet.109.152256.

10.
11.

Enhanced excitability of MRGPRA3- and MRGPRD-positive nociceptors in a model of inflammatory itch and pain.

Qu L, Fan N, Ma C, Wang T, Han L, Fu K, Wang Y, Shimada SG, Dong X, LaMotte RH.

Brain. 2014 Apr;137(Pt 4):1039-50. doi: 10.1093/brain/awu007.

12.

Frontiers in pruritus research: scratching the brain for more effective itch therapy.

Paus R, Schmelz M, Bíró T, Steinhoff M.

J Clin Invest. 2006 May;116(5):1174-86. Review.

13.

Enhanced scratching elicited by a pruritogen and an algogen in a mouse model of contact hypersensitivity.

Fu K, Qu L, Shimada SG, Nie H, LaMotte RH.

Neurosci Lett. 2014 Sep 5;579:190-4. doi: 10.1016/j.neulet.2014.03.062.

14.

Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog.

Hägermark O, Strandberg K, Hamberg M.

J Invest Dermatol. 1977 Dec;69(6):527-30.

PMID:
925375
15.

Enhancement of experimental pruritus and mechanically evoked dysesthesiae with local anesthesia.

Atanassoff PG, Brull SJ, Zhang J, Greenquist K, Silverman DG, Lamotte RH.

Somatosens Mot Res. 1999;16(4):291-8.

PMID:
10632026
16.

Itch--mediators and mechanisms.

Schmelz M.

J Dermatol Sci. 2002 Feb;28(2):91-6. Review.

PMID:
11858946
17.

Production of acute and chronic itch with histamine and contact sensitizers in the mouse and guinea pig.

Laidlaw A, Flecknell P, Rees JL.

Exp Dermatol. 2002 Aug;11(4):285-91.

PMID:
12190936
18.

Anti pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen-induced scratching behavior.

Sekine R, Satoh T, Takaoka A, Saeki K, Yokozeki H.

Exp Dermatol. 2012 Mar;21(3):201-4. doi: 10.1111/j.1600-0625.2011.01433.x.

PMID:
22379965
19.

Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice.

Andoh T, Nishikawa Y, Yamaguchi-Miyamoto T, Nojima H, Narumiya S, Kuraishi Y.

J Invest Dermatol. 2007 Aug;127(8):2042-7.

20.

Repetitive scratching and noxious heat do not inhibit histamine-induced itch in atopic dermatitis.

Ishiuji Y, Coghill RC, Patel TS, Dawn A, Fountain J, Oshiro Y, Yosipovitch G.

Br J Dermatol. 2008 Jan;158(1):78-83.

PMID:
17986304
Items per page

Supplemental Content

Support Center